Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Human clinical-trial data (Phase 1/2 studies in wound healing, cardiac injury, and dry eye) exist only for a different, full-length recombinant thymosin beta-4 product, not for the short synthetic fragment marketed as TB-500, so no completed published human trial has evaluated TB-500 specifically for muscle, tendon, or joint recovery
Not for human use, medical, veterinary or household purposes
BPC-157 is a synthetic peptide derived from a protective protein sequence studied for its role in cellular signaling and peptide research environments
Dihexa operates at a deeper, more structural level
Seek urgent medical care if you think you are having a serious allergic reaction
BPC-157 does not cause traditional tolerance or require post-cycle therapy like hormonal compounds
US$ 25.69
US$ 23.53
US$ 24.58
US$ 29.75
US$ 20.93
US$ 28.39
US$ 28.80
US$ 26.98
